• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝神经内分泌癌 11 例临床分析。

Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.

机构信息

Department of Special Treatment and Liver Transplantation, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):44-8.

PMID:20133228
Abstract

BACKGROUND

Primary hepatic neuroendocrine carcinoma (PHNEC) is extremely rare, and fewer than 300 cases have been reported in the English/Chinese-language literature, therefore it is difficult to make a proper diagnosis and determine a therapeutic approach.

METHODS

Eleven PHNEC patients were admitted to our hospital between January 1996 and May 2008. Laboratory examination, digestive endoscopy, B-ultrasonography, CT, MRI, or PET-CT were performed on the patients for preoperative diagnosis. All patients received liver resection. Some patients received transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection treatment (PEIT), or octreotide injection when a recurrence was found. The patients' clinical data were recorded and all patients were followed up.

RESULTS

The patients were confirmed pathologically as having PHNEC . Their median follow-up time was 33 months (12-107 months). All patients survived, and the longest post-operative survival time was 107 months, the longest disease-free survival time was 98 months, the 1-year survival rate was 100%, and the 1-year recurrence rate was 45.5% (5/11).

CONCLUSIONS

Since PHNEC is easy to confuse with hepatocellular carcinoma, careful screening of symptoms is needed to avoid misdiagnosis. Resection is the first choice of treatment for PHNEC and provides the most favorable outcomes including long-term survival. Other treatment such as TACE and PEIT can be considered as well, especially when a tumor recurs.

摘要

背景

原发性肝神经内分泌癌(PHNEC)极为罕见,英文和中文文献中报道的病例不足 300 例,因此难以做出正确诊断和确定治疗方法。

方法

1996 年 1 月至 2008 年 5 月期间,我院收治了 11 例 PHNEC 患者。对患者进行实验室检查、消化内镜、B 超、CT、MRI 或 PET-CT 检查以进行术前诊断。所有患者均接受了肝切除术。部分患者在发现复发时接受了经导管动脉化疗栓塞术(TACE)、经皮乙醇注射治疗(PEIT)或奥曲肽注射治疗。记录患者的临床资料并对所有患者进行随访。

结果

患者经病理检查确诊为 PHNEC。中位随访时间为 33 个月(12-107 个月)。所有患者均存活,最长术后生存时间为 107 个月,最长无病生存时间为 98 个月,1 年生存率为 100%,1 年复发率为 45.5%(5/11)。

结论

由于 PHNEC 容易与肝细胞癌混淆,因此需要仔细筛查症状以避免误诊。肝切除术是 PHNEC 的首选治疗方法,可提供包括长期生存在内的最有利结局。也可以考虑其他治疗方法,如 TACE 和 PEIT,特别是在肿瘤复发时。

相似文献

1
Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.原发性肝神经内分泌癌 11 例临床分析。
Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):44-8.
2
Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.原发性肝神经内分泌癌的临床特征和预后。
J Gastroenterol Hepatol. 2012 Aug;27(8):1306-11. doi: 10.1111/j.1440-1746.2012.07117.x.
3
Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.经导管动脉化疗栓塞术联合经皮乙醇注射治疗不可切除的大肝细胞癌:局部治疗效果和生存率评估
Hepatogastroenterology. 2001 Sep-Oct;48(41):1409-15.
4
[Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].经皮射频消融联合经动脉化疗栓塞及经皮乙醇注射治疗复发性小肝细胞癌
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1626-8.
5
Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.在一项回顾性研究中,根据意大利肝癌治疗方案评分得出的345例肝细胞癌患者在接受多模式治疗后的10年生存率。
J Gastroenterol Hepatol. 2008 Mar;23(3):482-90. doi: 10.1111/j.1440-1746.2007.05262.x. Epub 2007 Dec 13.
6
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.局部三维适形放疗联合经动脉化疗栓塞治疗Ⅲ期肝细胞癌患者的研究
Am J Clin Oncol. 2003 Aug;26(4):e92-9. doi: 10.1097/01.COC.0000077936.97997.AB.
7
[Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].[磁共振成像在经皮乙醇注射(PEI)或经动脉化疗栓塞(TACE)治疗肝癌随访中的作用]
Radiol Med. 1994 Dec;88(6):806-17.
8
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.术前经导管肝动脉化疗栓塞对肝细胞癌肝切除术后无病生存期的影响。
Cancer. 2000 Dec 15;89(12):2606-12.
9
[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].经导管肝动脉化疗栓塞术治疗肝癌切除术后复发性肝细胞癌
Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):380-2.
10
[Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].[肝癌化疗栓塞与酒精注射联合治疗。长期结果]
Radiol Med. 1997 Jul-Aug;94(1-2):19-23.

引用本文的文献

1
Interventional Combined Microwave Ablation for Primary Neuroendocrine Carcinoma of the Liver Failing Systemic Chemotherapy: A Case Report.介入联合微波消融治疗经全身化疗失败的原发性肝神经内分泌癌:一例报告
J Hepatocell Carcinoma. 2024 Nov 26;11:2351-2357. doi: 10.2147/JHC.S484272. eCollection 2024.
2
Primary hepatic neuroendocrine tumor with repeated diarrhea and flushing face: A case report and literature review.原发性肝神经内分泌肿瘤伴反复腹泻和面部潮红:一例报告并文献复习
Heliyon. 2024 Sep 27;10(19):e38606. doi: 10.1016/j.heliyon.2024.e38606. eCollection 2024 Oct 15.
3
Response to hepatic arterial infusion chemotherapy combined with camrelizumab and targeted therapy in advanced primary hepatic neuroendocrine carcinoma: a case report and literature review.
肝动脉灌注化疗联合卡瑞利珠单抗及靶向治疗晚期原发性肝神经内分泌癌的疗效:1例病例报告及文献复习
J Gastrointest Oncol. 2024 Aug 31;15(4):1962-1972. doi: 10.21037/jgo-24-571. Epub 2024 Aug 28.
4
Extended Left Hemihapatectomy with Right Hepatic Artery Reconstruction for Primary Hepatic Neuroendocrine Neoplasm: A Brief Report.左半肝切除术联合右肝动脉重建治疗原发性肝脏神经内分泌肿瘤:简要报告。
Am J Case Rep. 2024 Jun 18;25:e943721. doi: 10.12659/AJCR.943721.
5
Primary Hepatic Neuroendocrine Carcinoma with Metastasis to the Mesentery: A Case Report.原发性肝神经内分泌癌伴肠系膜转移:一例报告
Case Rep Oncol. 2023 Aug 22;16(1):681-697. doi: 10.1159/000533199. eCollection 2023 Jan-Dec.
6
Pediatric Ectopic Cushing Syndrome Caused by Hepatic Neoplasms: A Case Report and Systematic Review.肝脏肿瘤所致儿童异位库欣综合征:一例报告及系统评价
Cureus. 2023 Mar 29;15(3):e36852. doi: 10.7759/cureus.36852. eCollection 2023 Mar.
7
Primary hepatic origin of a neuroendocrine tumor: A rare case report.神经内分泌肿瘤的原发性肝起源:一例罕见病例报告。
Ann Med Surg (Lond). 2022 Nov 14;84:104937. doi: 10.1016/j.amsu.2022.104937. eCollection 2022 Dec.
8
Primary hepatic neuroendocrine carcinoma with colon adenoma: A case report with literature review.原发性肝神经内分泌癌合并结肠腺瘤:一例报告并文献复习
Int J Surg Case Rep. 2022 Jun;95:107176. doi: 10.1016/j.ijscr.2022.107176. Epub 2022 May 10.
9
Primary Hepatic Neuroendocrine Carcinoma with Thrombocytopenia Due to Diffuse Bone Marrow and Splenic Infiltration: An Autopsy Case.原发性肝神经内分泌癌伴血小板减少症,源于骨髓弥漫性浸润和脾脏浸润:尸检病例。
Intern Med. 2022 Nov 15;61(22):3361-3368. doi: 10.2169/internalmedicine.9465-22. Epub 2022 Apr 9.
10
Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study.化疗与经动脉化疗栓塞术治疗晚期原发性肝神经内分泌癌的疗效及预后因素分析:一项回顾性研究
Cancer Manag Res. 2021 Dec 10;13:9085-9093. doi: 10.2147/CMAR.S343572. eCollection 2021.